HAS1 and cancer: To determine whether these findings might have relevance in the context of human melanoma, we analysed mRNA expression data in the cancer genome atlas (TCGA) database35,36 derived from cutaneous melanomas, to assess whether coordinate expression of Id1 and/or Id3 with HAS genes or CD44 correlates with reduced survival.